Discovery of a CNS active GSK3 degrader using orthogonally reactive linker screening
Abstract Bifunctional targeted protein degraders, also known as Proteolysis Targeting Chimeras (PROTACs), are an emerging drug modality that may offer a new approach for treating neurodegenerative diseases. Identifying chemical starting points for PROTACs remains a largely empirical process and the...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Portfolio
2025-10-01
|
| 叢編: | Nature Communications |
| 在線閱讀: | https://doi.org/10.1038/s41467-025-63928-8 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|
